ir.novavax.com
U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine - May 19, 2025
Nuvaxovid™ is the only recombinant protein-based, non-mRNA COVID-19 vaccine available in the U.S. Biologics License Application approval triggers $175 million Sanofi milestone payment, with...